DRW Securities, LLC
Broker-DealerPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1481986
CHICAGO, IL
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$407,953
-$48,994 QoQ
Shares Held
528
-10.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DRW Securities, LLC holds $13,086,376 across 39 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CNTN |
Canton Strategic Holdings, Inc.
|
1,724,618 | $4,863,422 | |
| 2 | ARGX |
Argenx SE
|
947 | $878,598 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
1,731 | $493,283 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
17,111 | $432,908 | |
| 5 | SVRA |
Savara Inc
|
69,638 | $428,970 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
22,294 | $378,329 | |
| 7 | IMNM |
Immunome Inc.
|
17,686 | $374,766 | |
| 8 | INCY |
Incyte Corp
|
3,100 | $351,416 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $407,953 | 528 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $456,947 | 592 | Shares | Other | 2026-02-12 | |
| 2025-06-30 | $231,000 | 440 | Shares | Other | 2025-08-14 | |
| 2024-09-30 | $239,682 | 228 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $240,685 | 229 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $787,316 | 818 | Shares | Other | 2024-05-14 | |
| 2023-09-30 | $392,551 | 477 | Shares | Other | 2023-11-13 | |
| 2022-03-31 | $277,272 | 397 | Shares | Other | 2022-05-12 | |
| 2021-06-30 | $316,692 | 567 | Shares | Other | 2021-08-12 | |
| 2020-03-31 | $253,910 | 520 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||